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Background: Several lumbar disc prostheses are being developed with the goal of preserving mobility in patients with
degenerative disc disease. The disadvantage of lumbar artificial disc replacement (ADR) compared with anterior
interbody fusion (ALIF) is the increased potential for displacement or component failure. Revision or removal of the
device is complicated by adherence of the aorta, iliac vessels, and the ureter to the operative site. Because of these risks of
anterior lumbar procedures, vascular surgeons usually provide access to the spine. We report our experience with
secondary exposure of the lumbar spine for revision or explantation of the Charité disc prosthesis.
Methods: Between January 2001 and May 2006, 19 patients with prior implantation of Charité Artificial Discs required
21 operations for repositioning or removal of the device. Two patients had staged removal of prostheses at two levels. One
patient had simultaneous explantation at two levels. The mean age was 49 years (range, 31 to 69 years; 56% men, 42%
women). The initial ADR was performed at our institution in 14 patients (74%). The mean time from implantation to
reoperation was 7 months (range, 9 days to 4 years). The levels of failure were L3-4 in one, L4-5 in nine, and L5-S1 in 12.
Results: The ADR was successfully removed or revised in all patients that underwent reoperation. Three of the 12
procedures at L5-S1 were performed through the same retroperitoneal approach as the initial access. One of these three,
performed after a 3-week interval, was converted to a transperitoneal approach because of adhesions. The rest of the
L5-S1 prostheses were exposed from a contralateral retroperitoneal approach. Four of the L4-5 prostheses were accessed
from the original approach and five from a lateral, transpsoas exposure (four left, one right). The only explantation at
L3-4 was from a left lateral transpsoas approach. Nineteen of the 22 ADR were converted to ALIF. Two revisions at
L5-S1 involved replacement of the entire prosthesis. One revision at L4-5 required only repositioning of an endplate.
Access-related complications included, in one patient each, iliac vein injury, temporary retrograde ejaculation, small-
bowel obstruction requiring lysis, and symptomatic, large retroperitoneal lymphocele. There were no permanent
neurologic deficits, deep vein thromboses, or deaths.
Conclusions: Owing to vascular and ureteral fixation, anterior exposure of the lumbar spine for revision or explantation
of the Charité disc replacement should be performed through an alternative approach unless the procedure is performed
<2 weeks of the index procedure. The L5-S1 level can be accessed through the contralateral retroperitoneum.
Reoperation at L3-4 and L4-5 usually requires explantation and fusion that is best accomplished by way of a lateral
transpsoas exposure. ( J Vasc Surg 2006;44:1266-72.)During the last 15 years, the number of anterior lumbar
spinal reconstructions for degenerative disc disease has
significantly increased. The evolution of spine technology
has changed the occasional anterior procedure through a
large flank incision to commonplace fusions through a
direct anterior extraperitoneal exposure. Because of the
proximity of the lumbar spine to the aorta, inferior vena
cava, and the iliac vessels, anterior exposures are frequently
performed by vascular surgeons.
Despite high rates of radiographic fusion using cages
and allografts, long-term outcomes are limited by persis-
tent back pain, loss of mobility, and the development of
adjacent level degenerative disease. These complications
From the Divisions of Vascular Surgery,a Orthopedics,b and Neurosurgery,c
Cedars-Sinai Medical Center and Century City Doctors Hospital.
DePuy Spine, Inc, a Johnson & Johnson, company provided research
funding for performance of the clinical study of the Charité prosthesis.
Competition of interest: Dr Regan receives royalties from DePuy Spine and
Dr Johnson is a paid consultant for DePuy Spine.
Reprint requests: Willis H. Wagner, MD, Division of Vascular Surgery,
Cedars-Sinai Medical Center, 8631 W Third St, No 615-E, Los Angeles,
CA 90048 (e-mail: wagnerwh@cshs.org).
0741-5214/$32.00
Copyright © 2006 by The Society for Vascular Surgery.
doi:10.1016/j.jvs.2006.07.046
1266have led to the development of prostheses designed to
allow normal flexion, extension, and rotation.
The first device available in the United States is the
Charité artificial disc replacement (ADR), which was devel-
oped in Berlin in the mid-1980s and has been implanted
worldwide in 15,000 patients.1 A randomized trial com-
paring Charité ADR with anterior lumbar interbody fusion
(ALIF) was completed in December 2001, and US Food
and Drug Administration (FDA) approval followed in
October 2004.2 In the first year after FDA approval, ap-
proximately 4000 devices were implanted.3
The Charité device consists of two metal alloy endplates
with a sliding polyethylene core (Fig 1). Causes of removal
or revision of the prosthesis are multifactorial and are
related to technical errors at implantation, use of the pros-
thesis for non-FDA-approved indications such as multi-
level disease, and persistence of symptoms. We report our
experience with explantation and revision of the Charité
ADR, focusing on lessons learned that may minimize vas-
cular and ureteral injuries.
PATIENTS AND METHODS
Patients. Between January 2001 and May 2006, 19
patients with Charité ADR devices required 21 reopera-
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dence (n 2) of the prosthesis or persistent biomechanical
back pain despite posterior fusion (n  1). During this
period, we performed 1143 anterior thoracolumbar expo-
sures, predominantly ALIFs for degenerative disc disease at
L4-5 and L5-S1. Two patients had staged removal of
prostheses at two levels, and one patient had simultaneous
explantation at two levels. The mean age was 49 years
(range, 31 to 69 years), and 58% were men, and 42% were
women.
The initial ADR was performed in Europe before FDA
approval in four patients who did not wish to be subjects in
the American randomized trial of ALIF vs ADR. One
patient had his disc replacement in another state. The
remaining 14 patients had their implantation done by six
spine surgeons at our two hospitals. The mean time from
implantation to reoperation was 7 months (range, 9 days to
4 years). The levels of failure were L3-4 in one, L4-5 in
nine, and L5-S1 in 12. Individual patient data are given in
the Table.
Operative procedure for implantation. The skin in-
cision varied, depending on the levels exposed, but was
usually midline except for transverse incisions in women
Fig 1. Charité artificial lumbar disc replacement viewed from the
direct anterior (A) and superior oblique (B) perspective. Note
teeth that secure endplates to the vertebral body.who had a single-level ADR at L5-S1. The midline fasciawas incised along the medial border of the left rectus
muscle. The dissection plane was continued laterally under
the rectus muscle, anterior to the transversalis fascia and the
peritoneum. The transversalis fascia was incised laterally,
and the left portion of the peritoneum was retracted to the
right. The left ureter was usually seen but was never dis-
sected free from the peritoneal sac.
For L5-S1 exposure, the middle sacral artery and vein
were divided, and the iliac vessels were retracted laterally with
self-retaining retractors (Omni-Tract Surgical, St. Paul,
Minn). Exposure of L4-5 usually required division of the
left ascending lumbar (iliolumbar) vein. This allowed mo-
bilization of the distal aorta and left iliac artery and vein to the
right. Access to L3-4 was similar to L4-5 with additional
division of segmental vessels crossing the body of L3.
The disc spaces at each level were widely exposed with
retractor blades positioned laterally to the sympathetic
chains, on the downward slope of the vertebral bodies.
During the last 6 months, we have routinely placed a
polytetrafluoroethylene (PTFE) patch over the implanted
prosthesis to potentially facilitate secondary revision.
Operative procedure for reoperation. The approach
varied, depending on the timing of the re-exploration, the
level of exposure, and our accumulated experience. Ini-
tially, all re-explorations were performed through the orig-
inal anterior approach. Three of the 12 reoperations at
L5-S1 were performed through the standard left retroperi-
toneum. Two of these were accomplished 2 weeks after
the index procedure. The third was converted to a trans-
peritoneal exposure 3 weeks after implantation of the pros-
thesis owing to dense adhesions between the peritoneum
and the abdominal wall. The remaining nine exposures of
L5-S1 were through a contralateral right retroperitoneal
approach using the initial skin incision. This approach
mirrors the technique used for the primary exposure.
Early in our experience, we attempted to revise the
ADR at L4-5 through the initial approach. Adherence of
the iliac vessels to the spine prevented sufficient exposure to
safely replace the entire prosthesis anteriorly. Four of the
L4-5 prostheses were accessed from the original approach
and five from a direct lateral transpsoas exposure (4 left,
1 right). The transpsoas approach provided adequate access
to the lateral disc space to remove the prosthesis and
perform a fusion at both L4-5 and L3-4. The side of the
approach is determined by any lateral malpositioning of the
prosthesis. Because neither the aorta nor the vena cava is
mobilized for this exposure, either side is safe and provides
similar exposure.
After induction of anesthesia, the patient is placed in
the direct lateral decubitus (90°) position. The target disc
space is identified with fluoroscopy and marked on the skin
(Fig 2). In most cases, the patient is repositioned with the
elevated kidney rest under the appropriate level to open the
space between the iliac crest and the costal margin. An 8-cm
to 10-cm transverse skin incision centered over the target
disc is made between the anterior and posterior axillary
lines. When the L4-5 disc space is below the iliac crest, an
oblique incision is made 1 cm above the crest.
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fibers. The peritoneum is retracted medially to expose the
psoas muscle. The disc spaces can be palpated as raised
Table. Patient characteristics, levels of anterior lumbar dis
complications*
Age/sex Index levels Level of failure
Time to
revision
40M L4-5 & L5-S1 L5-S1 2 months Contrala
31M L5-S1 L5-S1 21 days Transpe
46M L5-S1 L5-S1 12 days Contrala
49F L5-S1 L5-S1 21 days Contrala
53M L4-5 & L5-S1 L5-S1 2 weeks Contrala
50F L5-S1 L5-S1 13 days Ipsilater
51F† L4-5 & L5-S1 L5-S1 11 months Contrala
51F L5-S1 L5-S1 4 years Contrala
69M L5-S1 L5-S1 11 days Contrala
49M L5-S1 L5-S1 14 months Contrala
56F† L4-5 & L5-S1 L5-S1 2 months Contrala
50F L4-5 & L5-S1 L4-5 & L5-S1 9 days Ipsilater
52M L4-5 L4-5 2 months Ipsilater
40M L4-5 L4-5 14 months Right la
37F L4-5 & L5-S1 L4-5 2 months Ipsilater
54F L4-5 & L5-S1 L4-5 11 days Ipsilater
51F† L4-5 & L5-S1 L4-5 6 months Left late
56F† L4-5 & L5-S1 L4-5 2 months Left late
42M L4-5 L4-5 24 months Left late
55M L4-5 L4-5 12 months Left late
54M L3-4 L3-4 6 months Left late
ALIF, Anterior interbody lumbar fusion; PSF, posterior spinal fusion; ADR
*Patients are listed by level of revision and secondarily in chronologic order
†Patients who had staged multilevel procedures.
Fig 2. Lateral image of ureteral (arrow) and L4-5 disc space dem-
onstrate anterior location of ureter during transpsoas exposure.ridges medial to the psoas muscle. After fluoroscopic con-firmation of the correct level, the psoas muscle is bluntly
divided longitudinally. Electrocautery is necessary to re-
lease attachments of the muscle to the spine but should be
limited owing to proximity to nerve roots.
The renal vein blades of the retractor system are used to
maintain exposure while the disc space is entered and the
spine surgeon retrieves the prosthesis. Ureteral stents were
placed before two of the late anterior re-exposures and two
of left lateral access at L4-5. We no longer use ureteral
stents for the transpsoas approach because the ureters are
sufficiently anterior to the plane of dissection to avoid
injury. Only one patient (L5-S1) has had anterior reopera-
tion since routine placement of a PTFE patch over the
prosthesis. Although there was a significant inflammatory
rind over the patch, longitudinal division of the PTFE
facilitated mobilization of the adjacent iliac veins.
RESULTS
The Charité prosthesis was successfully revised or re-
moved in all patients that underwent reoperation. Anterior
re-exposure of L5-S1 was sufficiently wide to allow replace-
ment with a smaller prosthesis in two patients. The other 10
ADR at L5-S1 were converted to ALIF. Only one patient
had revision at L4-5. This patient fell 2 months after her
ADR, resulting an anterior displacement of the superior
endplate of 2 to 3 mm. Although anterior exposure was
difficult, the endplate could be repositioned through a
lacement and revision, operative approach, and
ach Procedure Exposure complications
anterior L5-S1 ALIF Temporary retrograde
ejaculation
al L5-S1 ALIF & PSF Left iliac vein injury
anterior L5-S1 ALIF & PSF None
anterior L5-S1 revision ADR None
anterior L5-S1 revision ADR None
erior L5-S1 ALIF & PSF None
anterior L5-S1 ALIF & PSF None
anterior L4-5, L5-S1 ALIF
& PSF
None
anterior L5-S1 ALIF & PSF None
anterior L5-S1 ALIF & PSF Small-bowel obstruction
anterior L5-S1 ALIF & PSF None
erior L4-5 & L5-S1 ALIF
& PSF
Retroperitoneal lymphocele
erior L4-5 ALIF & PSF None
transpsoas) L4-5 ALIF & PSF None
erior L4-5 revision ADR None
erior L4-5 ALIF & PSF None
ranspsoas) L4-5 ALIF & PSF None
ranspsoas) L4-5 ALIF & PSF None
ranspsoas) L4-5 ALIF & PSF None
ranspsoas) L4-5 ALIF & PSF None
ranspsoas) L3-4 ALIF & PSF None























, artifilimited exposure. The remaining eight patients with L4-5
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ALIF.
Ureteral stents were placed prophylactically in four
patients having revision at L4-5. There were no ureteral
complications. One gastrointestinal complication occurred
in a patient who had re-exposure at L5-S1 through a
contralateral retroperitoneal approach. Although the peri-
toneum was not violated, a small bowel obstruction devel-
oped 3 weeks later that required exploration at another
institution. In one patient who had transperitoneal conver-
sion at L5-S1, an iliac vein injury occurred during removal
of the prosthesis. This was repaired primarily without se-
quelae.
One obese patient fell while leaving the hospital after
ADR at L4-5 and L5-S1. At the time of reoperation, she was
found to have a large lymphocele from the division of abun-
dant retroperitoneal soft tissue at her initial procedure. This
fluid collection reaccumulated, causing significant pain and
anorexia. Computed tomographic urography showed mod-
erate proximal hydronephrosis without extravasation and
fluid analysis (fluid creatinine 0.4 mg/dL) was inconsistent
with ureteral injury. The patient’s symptoms and hydrone-
phrosis resolved after laparoscopic marsupialization of the
lymphocele (Fig 3).
In the first patient in our series, whose initial surgery
was a multilevel ADR in Europe, retrograde ejaculation
developed after removal of the L5-S1 prosthesis and ALIF.
His sexual function returned to normal over several months.
There were no deep vein thromboses, permanent neu-
rologic complications, or deaths. The transpsoas approach
was not associated with any neurologic morbidity.
DISCUSSION
Spinal fusion surgery has been increasing steadily dur-
ing the last decade. Between 1996 and 2001, the number
of spinal fusions in the United States rose by 77%.4 Multiple
factors may explain this increase, including changes in the
population, advances in spinal imaging and surgical tech-
nique, and the development of human recombinant bone
morphogenetic protein, which obviates the harvest of iliac
crest donor bone. Coincident with the rise in fusions was
the FDA approval of threaded intervertebral cages. Many of
these devices were designed to be placed through a direct
anterior lumbar approach.5
A recent meta-analysis of surgical approach for isthmic
spondylolisthesis indicated a superiority of combined ante-
rior and posterior procedures in achieving fusion and suc-
cessful clinical outcome.6 Laparoscopic approaches were
popularized in the mid-1990s7-9 but have declined in re-
cent years owing to increased risks of vascular injury and
retrograde ejaculation, prolonged operating time, and in-
creased expenses relative to open, retroperitoneal ac-
cess.10-13 The rapid increase in anterior spine surgery has
created a demand for access surgeons familiar with retro-
peritoneal procedures and skilled at mobilizing vessels.14-16
Lumbar fusion is intended to alleviate pain by eliminat-
ing motion. Unfortunately, successful fusion may result in
degeneration of adjacent level discs.17,18 Reoperations atlevels adjacent to a lumbar fusion have been reported at
20% to 36% during long-term follow-up of 7 to 10
years.19,20 In addition, a radiographically successful fusion
may not eliminate pain or restore function.21 Analogous to
knee and hip replacement, ADR was designed to eliminate
pain from degenerative disc disease while restoring normal
motion.
The Charité ADR is the first lumbar device approved in
the United States. The current generation of this device has
been implanted in Europe since 1987. Long-term Euro-
pean data show good or excellent clinical outcome rates of
90%, with 92% of patients returning to work.22-24 A pro-
spective, randomized, multi-institutional trial of Charité
ADR vs ALIF showed that ADR patients recovered faster
and were significantly more satisfied with their treatment.
ADR was associated with shorter hospital stays, comparable
perioperative complication rates, and lower rates of reop-
Fig 3. A, Large retroperitoneal lymphocele that developed after
initial anterior exposure of L4-5 and L5-S1 and expanded after
re-exposure for removal and anterior lumbar interbody fusion. B,
One month after laparoscopic marsupialization, the fluid collec-
tion completely resolved.eration at 2 years.2
JOURNAL OF VASCULAR SURGERY
December 20061270 Wagner et alAccess-related complications are frequently the most
serious problems encountered with either ADR or ALIF.
Many spine surgeons have avoided anterior lumbar proce-
dures because of this concern. Iatrogenic major arterial or
venous injuries occur in 2% to 5% of anterior lumbar
exposures.2,25-28 The risk of vascular injury is higher at
L4-5 than L5-1 (6.2% vs 1.2%) and is increased tenfold by
the instrumentation used to place threaded devices, such as
fusion cages.26,28 Vascular injuries during the initial ante-
rior lumbar procedure are not usually due to the exposure,
but are more likely to occur during placement of cages or
grafts.2
Toe pulse oximetry and somatosensory evoked poten-
tials (SSEP) are useful indicators of arterial thrombo-
sis.26,29 We frequently see transient changes in left leg SSEP
with prolonged arterial retraction that does not cause any
postoperative deficit. Deep vein thrombosis and pulmonary
emboli that occur after 1% or 2% of major reconstructive
spine operations are more common after anterior lumbar
surgery.27,30,31
The reported incidence of retrograde ejaculation in
men is 0.4% to 8%32-34 and is related to the method of
exposure. During open retroperitoneal access, the sympa-
thetic nerve-bearing tissue is bluntly retracted medially
along with the peritoneal sac. Laparoscopic or open trans-
peritoneal exposure frequently causes division of the supe-
rior hypogastric plexus, with a resulting increase in sexual
dysfunction.9,13,35 Repeat exposure of the lumbar spine
from a direct anterior approach significantly increases the
risk of retrograde ejaculation. The nerve-bearing tissue that
was previously retracted medially is now adherent to the
operative field. The patient in our series who experienced
temporary retrograde ejaculation had a contralateral retro-
peritoneal exposure of L5-S1. Although the dissection
down to the disc space was not difficult, it is likely that
retrograde ejaculation resulted from the cumulative effect
of bilateral mobilization of sympathetic fibers. The lateral
transpsoas exposure has not been associated with this risk of
sexual dysfunction.
Ureteral injuries are infrequently documented in case
reports or small series of anterior lumbar procedures.16,36,37 A
retrospective review of 471 ALIF procedures found one
ureteral injury (0.2%).28 We had a single ureteral injury in
our current series of 1143 anterior thoracolumbar expo-
sures performed for a variety of indications, including de-
generative disc disease, scoliosis, trauma, and infection. The
ureter was damaged by a screw placed from the posterior
approach that traversed the vertebral body during a primary
anteroposterior fusion, unrelated to the anterior exposure.
The incidence of complications that require revision or
removal of Charité ADR is uncertain. Lemaire et al23 reported
107 patients after a minimum of 10-year follow-up with no
explants. In the American multi-institutional trial, the revi-
sion and removal rates of 205 patients at 2 years were 2.4%
and 1%, respectively.2 Yet the rapid proliferation of this
technology in the last 2 years will certainly result in many
secondary anterior operations.There is a paucity of reported experience with ADR
revision and removal. The rapid scarring that fuses the iliac
vessels and the left ureter to the spine and obscures their
margins imposes significantly higher risk of complications
during these secondary procedures. Complete replacement
of an ADR requires significant side-to-side access to the
spine. Replacement of the device is much more feasible at
L5-S1 than L4-5 or L3-4. The contralateral retroperitoneal
approach to L5-S1 is still limited by adherence of the iliac
vessels to the spine. We use primarily blunt dissection to
identify the medial border of the common iliac vein and to
mobilize the vein just enough to permit removal and re-
placement of the prosthesis. Sharp dissection is perilous
owing to the indistinct borders of the vascular structures.
The advantage of the contralateral approach is an undis-
turbed plane back to the spine that makes ureteral and
vascular injuries less likely. A transperitoneal approach to
L5-S1 requires a larger incision, results in a longer postop-
erative ileus, and is associated with a higher rate of retro-
grade ejaculation. The iliac bone prevents the direct lateral
exposure used on more cephalad levels.
Even procedures performed between 1 and 2 weeks
postoperatively may not allow sufficient exposure of L4-5
to replace the ADR with a new prosthesis. Therefore, after
2 weeks, device dislocation or subsidence that requires
revision at L3-4 or L4-5 is best treated by removal and
fusion through a lateral access. This is a modification of an
endoscopic approach used for primary anterior lumbar
fusion previously reported from our institution.38
Before the advent of ADR, we preferentially used the
lateral transpsoas approach for obese patients who need
ALIF at L2-3 or L3-4. The incision used for this access is
significantly shorter than the large flank incisions common
more than a decade ago. Denervation injuries that result in
muscle bulging and patient dissatisfaction have not been
observed with this technique. The transpsoas approach
provides an undisturbed plane to reach the lateral disc space
without significant risk of vascular or ureteral injury.
An inflammatory rind rapidly forms over the disc pros-
thesis, which separates the device from the overlying ves-
sels. Similar to results reported with primary anterior fu-
sion, vascular injury during the lateral approach is more
likely to occur during instrumentation to extract the ADR
and place an allograft or other devices than during the
exposure. Fluoroscopic visualization of the stent during
lateral exposure shows that the operative field is signifi-
cantly posterior to the course of the ureter. We no longer
use ureteral stents in patients who undergo transpsoas
access for Charité removal; however, we believe that when
the anatomy or indications mandate anterior re-exploration
through the original approach, stents may have merit.
We have not encountered any difficulty removing the
prosthesis from either the left or the right lateral approach.
The only disadvantage of the transpsoas exposure is the
potential for local nerve trauma. Bergey et al38 documented
a 30% incidence of postoperative transient groin or thigh
discomfort, or both, due to genitofemoral nerve irritation,
which usually resolves after 4 weeks. This complication only
JOURNAL OF VASCULAR SURGERY
Volume 44, Number 6 Wagner et al 1271occurred in patients who had multiple level exposures and
was not seen in the current series. It is also important to
dissect through the anterior one third of the psoas muscle
to avoid nerve root injury. Intraoperative neurologic sur-
veillance is particularly important at the L4-5 level where
the L3 nerve root may traverse the disc space when ap-
proached laterally.
The Charité ADR endplate has small teeth that are
easily dislodged from a lateral approach. Newer designed
lumbar prostheses, such as the ProDisc (Synthes, West
Chester, Pa) and Maverick (Medtronic Sofamor Danek,
Memphis, Tenn) ADR, have large midline keels that may
prevent lateral removal.
Bertagnoli et al39 have suggested several strategies to
facilitate revisions. The first is a “strategic” approach to
keep the left L4-5 region undisturbed for future surgery.
He recommended that index operations at L5-S1 be done
from the right side, with revisions performed through a
transperitoneal approach. This leaves the left retroperito-
neum available for more proximal level access in the future.
Another strategy, which we independently adopted in mid-
2005, is placement of an antiadhesive membrane (PTFE)
between the vessels and the prosthesis. We have reoperated
anteriorly on one patient with an L5-S1 prosthesis after this
technique. In this case, once the PTFE was encountered,
the dissection of the ADR from the iliac vessels appeared
easier than in prior cases. Finally, Bertagnoli et al have
recommended that future prostheses should have a modu-
lar design that would allow revision through a limited
exposure or placement through a lateral approach that may
be easier to revise.
CONCLUSION
Malposition or dislocation of Charité lumbar disc pros-
theses that require revision 2 weeks can usually be ex-
posed through the same anterior retroperitoneal access.
Later revisions at L5-S1 should be undertaken through a
similar right retroperitoneal approach. Scarring and fixation
of the vessels and the left ureter limit anterior exposure of
proximal lumbar levels after 2 weeks. In most cases, explan-
tation of the prosthesis and fusion through a lateral transp-
soas approach is the best option for devices at L4-5 and
above. Placement of a PTFE membrane over the prosthesis
at the index procedure may prevent adhesion of the vessels
to the spine and allow safer anterior revision.
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